GreenGro Technologies Inc (GRNH)

[RookieStockPicker]

$GRNH> Being ranked with such heavyweights as AmeriCann and Aurora Cannabis is by far one of GreenGro’s greatest single milestones since becoming a public company,” said James Haas, Chairman and CEO of GreenGro Technologies. “However, it wasn’t through sheer luck but rather intensive research and development, a certain tenacity to succeed that instills across all our employees and, of course, a loyal and longstanding consumer base. Although the newsletter highlighted our state-of-the-art greenhouses, I am excited to shortly be announcing what will mark the second and possibly faster growing segment of our business, our highly anticipated launch into the CBD market,” concluded Mr. Haas.
Company’s Expected Launch into the CBD Market
Cannabidiol, or CBD, is a component of the marijuana plant. Unlike THC, CBD cannot give you a sense of euphoria or make you intoxicated. What it can do, however, is provide anti-inflammatory, analgesic, anti-nausea and anti-seizure effects, according to industry experts. While THC acts on certain cannabinoid receptors found in the brain and central nervous system, CBD works throughout the body. GreenGro’s strategy all along was to allow the heavyweights, such as GW Pharmaceuticals and Insys Therapeutics, Inc. to spend the millions of research and development dollars it did not have to create the market for smaller yet more agile players such as GreenGro Technologies. The Company expects to update investors on its latest developments in this arena very shortly.
To be added to Gala Pharmaceutical’s investor lists, please contact Bill Miller at 844-565-5665 or via email at [e-mail].
Or like our Facebook page @
https://www.facebook.com/gala-pharmaceuticals-147596665868456


https://finance.yahoo.com/news/leading-investment-newsletter-ranks-greengro-121500425.html